Evidence map›Paper›PMID 41461033›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Ebola virus matrix protein VP40 triggers inflammatory responses linked to the ebolavirus virulence.

Satoko Yamaoka, Zeineb M'Hamdi, Lin Wang, Vaille A Swenson, Kristin L McNally, Shao-Chia Lu, Reema Singh, Stephanie L Saundh, Brady N Zell, Sonja M Best and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Satoko YamaokaDepartment of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-9768-5696
Zeineb M'HamdiVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
Lin WangDepartment of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-7757-0381
Vaille A SwensonVirology and Gene Therapy Track, Mayo Graduate School of Biomedical Sciences, Rochester, MN 55905.ORCID 0000-0002-1706-1833
Kristin L McNallyLaboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.
Shao-Chia LuDepartment of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-5701-4433
Reema SinghVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.ORCID 0000-0001-7049-5473
Stephanie L SaundhVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.ORCID 0000-0001-7339-1063
Brady N ZellVirology and Gene Therapy Track, Mayo Graduate School of Biomedical Sciences, Rochester, MN 55905.ORCID 0000-0002-9755-950X
Sonja M BestLaboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840.ORCID 0000-0003-0206-297X
Michael A BarryDepartment of Medicine, Division of Infectious Diseases, Mayo Clinic, Rochester, MN 55905.ORCID 0000-0002-8568-5664
Angela L RasmussenVaccine and Infectious Disease Organization, University of Saskatchewan, Saskatoon, SK S7N 5E3, Canada.
Hideki EbiharaDepartment of Virology 1, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 162-8640, Japan.ORCID 0000-0002-2576-9735

Funding

Mechanisms of Ebola virus-mediated inflammatory activation linked to pathogenesisR01AI134937 · NIAID · MAYO CLINIC ROCHESTER · PI BARRY, MICHAEL A · 2019 to 2023
$3.3M
PhD Training Program in Virology and Gene TherapyT32AI132165 · NIAID · MAYO CLINIC ROCHESTER · PI ROBERTO B. CATTANEO · 2018 to 2026
$1.3M
Japan Agency for Medical Research and Development (AMED) JP22fk0108624NIAID NIH HHS R01 AI134937NIAID NIH HHS T32 AI132165
6 · The paper itself

Abstract

Uncontrolled systemic inflammatory responses are a critical pathological feature of fatal Ebola virus (EBOV) infection. While some inflammatory responses may originate from mononuclear phagocytes (MNPs), nonimmune cells vastly outnumber MNPs and may be an important source of inflammation. Here, we demonstrated that highly virulent EBOV induced a high and sustained pro-inflammatory response compared to less virulent ebolaviruses in non-MNPs through TLR4-independent NF-κB activation. We identified the EBOV matrix protein VP40 as a potent activator of NF-κB in non-MNPs, whose intrinsic inflammatory activation ability is higher than VP40 proteins from less virulent ebolaviruses. This suggests that VP40 is a virulence determinant inducing distinct degrees of pro-inflammatory responses among ebolaviruses. Mechanistically, VP40 activated the NF-κB signaling pathway, primarily via TNFR1 using a ligand-independent mechanism. These findings reveal mechanisms that may drive systemic inflammation and promote EBOV pathogenesis, suggesting potential therapeutic strategies to mitigate immune dysregulation in severe EBOV infections.

Indexed as

EbolavirusHemorrhagic Fever, EbolaInflammationViral Core ProteinsAnimalsHEK293 CellsHumansMiceNF-kappa BPhagocytesReceptors, Tumor Necrosis Factor, Type ISignal TransductionToll-Like Receptor 4Viral Matrix ProteinsVirulenceNF-kappa BReceptors, Tumor Necrosis Factor, Type IToll-Like Receptor 4Viral Core ProteinsViral Matrix ProteinsVP40 protein, virusfilovirusinflammationmatrix protein VP40NF-κBvirulence

Identifiers

PMID41461033
PMCPMC12773709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.